New Advances

Summary Neko Health raises $260 million to advance its full-body scanning technology, aiming to revolutionize preventative healthcare. The funding will fuel expansion in Europe and the US, along with further research and development. With a […]

Summary This article explores a groundbreaking development in diabetes management: a gene switch activated by a nitroglycerin patch. This innovative technology offers the potential for precise, on-demand cell therapies, paving the way for a future […]

Summary New research reveals the best approach for treating strokes in medium-sized blood vessels. Surprisingly, less invasive methods prove equally effective as more complex procedures. This discovery has significant implications for stroke treatment, allowing doctors […]

Summary Medtronic’s Q3 FY25 revenue shows 2.5% growth, reaching $8.3 billion. While slightly below expectations, the company maintains its full-year guidance. This performance highlights ongoing advancements in medical technology, particularly in areas like pulsed field […]

Summary Boston Scientific secures CE mark for its groundbreaking Farapulse pulsed field ablation (PFA) system. This approval covers the innovative Farawave Nav ablation catheter and Faraview software, enhancing the treatment of paroxysmal atrial fibrillation. The […]

Summary Johnson & Johnson MedTech resumes the U.S. rollout of its Varipulse pulsed field ablation system after a temporary pause due to reported strokes. The company’s investigation found no device or procedure-related issues and updated […]

Summary Umbilical cord blood offers a unique snapshot of a baby’s health at birth. Scientists have identified proteins within cord blood that could serve as biomarkers for preterm birth risk and other complications. This discovery […]

Summary Medtronic’s Crescent RA jugular dual lumen catheter receives CE marking, a significant advancement in pediatric ECMO therapy. This innovative device offers a right atrial design and dual functionality for enhanced blood flow and stability, […]

Summary A recent clinical trial in China suggests that the clot-busting drug alteplase could be effective up to 24 hours after the onset of stroke symptoms, significantly expanding the treatment window. This finding offers new […]

Summary Globus Medical’s acquisition of Nevro for $250 million signals a strategic move into the neuromodulation market. This acquisition allows Globus to expand its musculoskeletal portfolio and offer comprehensive solutions for chronic pain. The deal, […]